ATE72565T1 - Verbindung cl-1577-b4, ihre herstellung und verwendung. - Google Patents

Verbindung cl-1577-b4, ihre herstellung und verwendung.

Info

Publication number
ATE72565T1
ATE72565T1 AT86301435T AT86301435T ATE72565T1 AT E72565 T1 ATE72565 T1 AT E72565T1 AT 86301435 T AT86301435 T AT 86301435T AT 86301435 T AT86301435 T AT 86301435T AT E72565 T1 ATE72565 T1 AT E72565T1
Authority
AT
Austria
Prior art keywords
compound
activity against
gram
sub
cell line
Prior art date
Application number
AT86301435T
Other languages
English (en)
Inventor
John H Wilton
Gerard C Hokanson
James C French
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE72565T1 publication Critical patent/ATE72565T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86301435T 1985-03-15 1986-02-28 Verbindung cl-1577-b4, ihre herstellung und verwendung. ATE72565T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/712,294 US4594248A (en) 1985-03-15 1985-03-15 CL-1577-B4 compound, its production and use
EP86301435A EP0194784B1 (de) 1985-03-15 1986-02-28 Verbindung CL-1577-B4, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE72565T1 true ATE72565T1 (de) 1992-02-15

Family

ID=24861526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86301435T ATE72565T1 (de) 1985-03-15 1986-02-28 Verbindung cl-1577-b4, ihre herstellung und verwendung.

Country Status (10)

Country Link
US (2) US4594248A (de)
EP (1) EP0194784B1 (de)
JP (1) JPH0689012B2 (de)
AT (1) ATE72565T1 (de)
AU (1) AU589943B2 (de)
CA (1) CA1253820A (de)
DE (1) DE3683860D1 (de)
DK (1) DK116286A (de)
ES (1) ES8706162A1 (de)
ZA (1) ZA861052B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use
US4921700A (en) * 1985-08-27 1990-05-01 Bristol-Myers Company BBM-1675c and d antitumor antibiotics
US4939244A (en) * 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
US4837206A (en) * 1987-04-29 1989-06-06 Bristol-Myers Company Esperamicin derivatives
US4952572A (en) * 1988-06-10 1990-08-28 Bristol-Myers Company BU-3420T antifungal antibiotic
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US5028536A (en) * 1989-03-15 1991-07-02 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41339
US5086045A (en) * 1989-03-15 1992-02-04 Bristol-Myers Squibb Company Antitumor antibiotic
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335108A (en) * 1980-08-25 1982-06-15 The Upjohn Company Paulomycin A and B and preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use

Also Published As

Publication number Publication date
CA1253820A (en) 1989-05-09
ZA861052B (en) 1987-09-30
DK116286D0 (da) 1986-03-13
EP0194784B1 (de) 1992-02-12
JPS61216692A (ja) 1986-09-26
US4594248A (en) 1986-06-10
JPH0689012B2 (ja) 1994-11-09
AU589943B2 (en) 1989-10-26
EP0194784A3 (en) 1987-12-09
DE3683860D1 (de) 1992-03-26
AU5337386A (en) 1986-09-18
ES8706162A1 (es) 1987-05-16
EP0194784A2 (de) 1986-09-17
ES553051A0 (es) 1987-05-16
DK116286A (da) 1986-09-16
US4661353A (en) 1987-04-28

Similar Documents

Publication Publication Date Title
AU4022393A (en) 5-O-desosaminylerythronolide a derivative
RU93050129A (ru) Новые производные эритромицина, метод их получения и фармацевтическая композиция на их основе и промежуточные соединения синтеза
EP0256542A3 (de) Cephemverbindungen
ATE72565T1 (de) Verbindung cl-1577-b4, ihre herstellung und verwendung.
AU585948B2 (en) Penem compounds, production and use thereof
EP0315147A3 (de) Antibiotika, Benanomicine A und B und Dexylosylbenanomicin B, ihre Herstellung und Verwendung
IE812859L (en) Azetidinones.
DE3580459D1 (de) Antibiotika-/antitumorverbindungen cl-1577d und cl-1577e, deren herstellung und verwendung.
ATE33390T1 (de) Antibiotikum, dessen herstellung sowie dessen verwendung.
EP0139553A3 (de) 1N-(omega-Amino-alpha-hydroxyalkanoyl)-2',3'-Dideoxykanamycin-A und Herstellung dieses Produktes
ES8801703A1 (es) Un nuevo procedimiento para producir el (los) antibiotico (s) macrolido (s) 4s-02930 k-d-e o-h.
EP0139457A3 (de) Antibiotische Verbindung und ihre Herstellung
DE3675424D1 (de) Valiolaminderivate und ihre herstellung.
IE40748L (en) Antibiotic 20,798 r.p.
ES8403907A1 (es) Un procedimiento para la produccion de nuevos derivados de los antibio-oa-6129, ca-6129 b1 y ca-6129b2
ATE48843T1 (de) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung.
AU571956B2 (en) 3-azinomethyl rifamycins
JPS54119468A (en) Novel antibiotic, nanaomycin e and its preparation
IE860279L (en) (oxy) difficol from b. subtilis
CA2158482A1 (en) UCF1 Compounds, Derivatives Thereof and Processes for Their Preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee